A simplified multivisceral transplantation procedure for patients with combined end-stage liver disease and type 2 diabetes mellitus
from Liver Transplantation
In liver transplant patients with type 2 diabetes mellitus (DM), the disease worsens after transplantation because of longterm use of diabetogenic immunosuppressive drugs, making management of those patients a great challenge. The objective of our study was to evaluate the safety and efficacy of a simplified multivisceral transplantation (SMT) procedure for the treatment of patients with end-stage liver disease and concurrent type 2 DM.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063